Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marilyn L. Browne is active.

Publication


Featured researches published by Marilyn L. Browne.


Hypertension | 2009

Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular Malformations

Alissa R. Caton; Erin M. Bell; Charlotte M. Druschel; Martha M. Werler; Angela E. Lin; Marilyn L. Browne; Louise-Anne McNutt; Paul A. Romitti; Allen A. Mitchell; Richard S. Olney; Adolfo Correa

We used data from the National Birth Defects Prevention Study, a population-based, case-control study, to examine whether previously reported associations between antihypertensive medications and cardiovascular malformations could be confirmed and to explore whether new associations might be identified. Cases (n=5021) were ascertained through birth defects surveillance systems from 1997 through 2003 in 10 US states. Controls (n=4796) were live births without birth defects selected randomly from birth certificates or hospital discharge listings in the same geographic regions. Logistic regression was used to examine the relationship between antihypertensive medication treatment and the occurrence of cardiovascular malformations while controlling for confounding variables. First-trimester treatment with antihypertensive medication was associated with pulmonary valve stenosis (odds ratio [OR]: 2.6; 95% CI: 1.3 to 5.4), Ebstein malformation (crude OR: 11.4; exact 95% CI: 2.8 to 34.1), coarctation of the aorta (OR: 3.0; 95% CI: 1.3 to 6.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Treatment initiated after the first trimester was associated with pulmonary valve stenosis (OR: 2.4; 95% CI: 1.1 to 5.4), perimembranous ventricular septal defects (OR: 2.3; 95% CI: 1.2 to 4.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Untreated hypertension was associated with Ebstein malformation (OR: 2.1; 95% CI: 1.0 to 4.3) and secundum atrial septal defects (OR: 1.3; 95% CI: 1.0 to 1.6). Antihypertensive medication use and/or the underlying hypertension might increase the risk of having an infant with specific left and right obstructive and septal defects. Additional studies with adequate power will be needed to confirm these findings.


Epidemiology | 2006

Maternal Exposure to Caffeine and Risk of Congenital Anomalies: A Systematic Review

Marilyn L. Browne

Background: Caffeine is teratogenic in animal studies when administered at high concentrations. Previous review articles have concluded that maternal caffeine consumption does not influence the risk of congenital anomalies. These reviews were narrative rather than systematic. The objective of the current systematic review is to provide a critical appraisal of epidemiologic evidence. Methods: A search of the MEDLINE/PUBMED database (1966–October 2004) was conducted for all published epidemiologic studies with maternal intake of caffeine as an exposure and major malformations as an outcome. Study characteristics were abstracted, internal validity evaluated, and study findings summarized. Results: Twenty-five papers met the initial criteria for inclusion, of which 18 were subsequently excluded as a result of other limitations. Effect estimates for the remaining 7 studies were generally close to null. Specific subgroup analyses were summarized across studies (associations between coffee and cardiovascular malformations, coffee and oral clefts, and tea and cardiovascular malformations). Summary point estimates ranged from 1.0 to 1.2; the upper limits of all confidence intervals were less than 1.7. Conclusions: There is no evidence to support a teratogenic effect of caffeine in humans. Current epidemiologic evidence is not adequate to assess the possibility of a small change in risk of congenital anomalies resulting from maternal caffeine consumption.


Birth Defects Research Part A-clinical and Molecular Teratology | 2009

Maternal caffeine consumption and risk of neural tube defects.

Rebecca J. Schmidt; Paul A. Romitti; Trudy L. Burns; Marilyn L. Browne; Charlotte M. Druschel; Richard S. Olney

BACKGROUND Animal studies demonstrate teratogenic effects of caffeine, whereas human studies are inconclusive. METHODS Associations between maternal caffeine consumption and neural tube defects (NTDs) by type of NTD (anencephaly, spina bifida, or encephalocele) were examined using data from the National Birth Defects Prevention Study (NBDPS). Total average daily caffeine from coffee, tea, soda, and chocolate consumption during the year before pregnancy was estimated for 768 mothers of infants with NTDs and 4143 mothers of infants without birth defects who gave birth during 1997 through 2002. Periconceptional use of caffeine-containing medications was evaluated separately. Adjusted odds ratios (OR) and 95% confidence intervals (CI) associated with consumption of total caffeine and each caffeine source were estimated from logistic regression models. RESULTS Positive associations were observed between spina bifida and total caffeine consumption (OR 1.4; 95% CI: 1.1-1.9) and each caffeine source except caffeinated tea, which showed a negative association with spina bifida (OR 0.7; 95% CI: 0.6-0.9). Associations with modestly increased risk of NTDs and encephalocele were also observed. The association between caffeine consumption and anencephaly differed by maternal race/ethnicity. No dose effects were found. CONCLUSIONS Additional studies should confirm whether women who consume caffeine are at increased risk for pregnancies complicated by NTDs.


Birth Defects Research Part A-clinical and Molecular Teratology | 2015

The national birth defects prevention study: A review of the methods

Jennita Reefhuis; Suzanne M. Gilboa; Marlene Anderka; Marilyn L. Browne; Marcia L. Feldkamp; Charlotte A. Hobbs; Mary M. Jenkins; Peter H. Langlois; Kimberly Newsome; Andrew F. Olshan; Paul A. Romitti; Stuart K. Shapira; Gary M. Shaw; Sarah C. Tinker; Margaret A. Honein

BACKGROUND The National Birth Defects Prevention Study (NBDPS) is a large population-based multicenter case-control study of major birth defects in the United States. METHODS Data collection took place from 1998 through 2013 on pregnancies ending between October 1997 and December 2011. Cases could be live born, stillborn, or induced terminations, and were identified from birth defects surveillance programs in Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah. Controls were live born infants without major birth defects identified from the same geographical regions and time periods as cases by means of either vital records or birth hospitals. Computer-assisted telephone interviews were completed with women between 6 weeks and 24 months after the estimated date of delivery. After completion of interviews, families received buccal cell collection kits for the mother, father, and infant (if living). RESULTS There were 47,832 eligible cases and 18,272 eligible controls. Among these, 32,187 (67%) and 11,814 (65%), respectively, provided interview information about their pregnancies. Buccal cell collection kits with a cytobrush for at least one family member were returned by 19,065 case and 6,211 control families (65% and 59% of those who were sent a kit). More than 500 projects have been proposed by the collaborators and over 200 manuscripts published using data from the NBDPS through December 2014. CONCLUSION The NBDPS has made substantial contributions to the field of birth defects epidemiology through its rigorous design, including case classification, detailed questionnaire and specimen collection, large study population, and collaborative activities across Centers.


Aerobiologia | 2001

Ambient air levels of Aspergillus fumigatus and thermophilic actinomycetes in a residential neighborhood near a yard-waste composting facility

Gregg M. Recer; Marilyn L. Browne; Edward G. Horn; Kenneth M. Hill; William F. Boehler

Composting is a biological process that has thepotential to emit large quantities ofbioaerosols and, therefore, could adverselyaffect public health. Numerous previousstudies have demonstrated bioaerosol levelselevated above background adjacent tocomposting waste materials, but effects onoffsite bioaerosol levels due tocomposting-facility bioaerosol emissions havenot been extensively investigated. Of the fewsuch studies published, most have not foundelevated compost-related bioaerosols downwindfrom the composting operation. We investigatedviable Aspergillus fumigatus andthermophilic actinomycete levels upwind anddownwind of a large yard-waste compostingfacility and sought to determine whether levelsin a residential neighborhood near the facilitywere elevated above background levels due tofacility bioaerosol emissions. Mean bioaerosollevels at the composting facility weresignificantly higher than the mean backgroundlevels, exceeding the background means byroughly 20-fold. When a neighborhood samplingsite about 500 m from the facility was in thedownwind direction mean levels weresignificantly higher than for other winddirections, and excursions well abovebackground levels were significantly morefrequent than at background sites. There was asignificant temporal correlation betweenbioaerosol levels at the composting facilityand the downwind sampling site. The resultsindicate that bioaerosol emissions from a largeyard-waste composting facility cansignificantly increase bioaerosol exposurelevels at least 500 m downwind from thefacility.


Pediatrics | 2012

Maternal Asthma Medication Use and the Risk of Selected Birth Defects

Shao Lin; Jean Pierre Munsie; Michele L. Herdt-Losavio; Charlotte M. Druschel; Kimberly A. Campbell; Marilyn L. Browne; Paul A. Romitti; Richard S. Olney; Erin M. Bell

OBJECTIVES: Approximately 4% to 12% of pregnant women have asthma; few studies have examined the effects of maternal asthma medication use on birth defects. We examined whether maternal asthma medication use during early pregnancy increased the risk of selected birth defects. METHODS: National Birth Defects Prevention Study data for 2853 infants with 1 or more selected birth defects (diaphragmatic hernia, esophageal atresia, small intestinal atresia, anorectal atresia, neural tube defects, omphalocele, or limb deficiencies) and 6726 unaffected control infants delivered from October 1997 through December 2005 were analyzed. Mothers of cases and controls provided telephone interviews of medication use and additional potential risk factors. Exposure was defined as maternal periconceptional (1 month prior through the third month of pregnancy) asthma medication use (bronchodilator or anti-inflammatory). Associations between maternal periconceptional asthma medication use and individual major birth defects were estimated by using adjusted odds ratios (aOR) and 95% confidence intervals (95%CI). RESULTS: No statistically significant associations were observed for maternal periconceptional asthma medication use and most defects studied; however, positive associations were observed between maternal asthma medication use and isolated esophageal atresia (bronchodilator use: aOR = 2.39, 95%CI = 1.23, 4.66), isolated anorectal atresia (anti-inflammatory use: aOR = 2.12, 95%CI = 1.09, 4.12), and omphalocele (bronchodilator and anti-inflammatory use: aOR = 4.13, 95%CI = 1.43, 11.95). CONCLUSIONS: Positive associations were observed for anorectal atresia, esophageal atresia, and omphalocele and maternal periconceptional asthma medication use, but not for other defects studied. It is possible that observed associations may be chance findings or may be a result of maternal asthma severity and related hypoxia rather than medication use.


Birth Defects Research Part A-clinical and Molecular Teratology | 2011

Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis

Sandra D. Richardson; Marilyn L. Browne; Sonja A. Rasmussen; Charlotte M. Druschel; Lixian Sun; Ethylin Wang Jabs; Paul A. Romitti

BACKGROUND Alcohol consumption during pregnancy is known to be associated with certain birth defects, but the risk of other birth defects is less certain. The authors examined associations between maternal alcohol consumption during pregnancy and craniosynostosis, omphalocele, and gastroschisis among participants in the National Birth Defects Prevention Study, a large, multicenter case-control study. METHODS A total of 6622 control infants and 1768 infants with birth defects delivered from 1997-2005 were included in the present analysis. Maternal alcohol consumption was assessed as any periconceptional consumption (1 month prepregnancy through the third pregnancy month), and by quantity-frequency, duration, and beverage type. Alcohol consumption throughout pregnancy was explored for craniosynostosis since the period of development may extend beyond the first trimester. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression analysis. OR were adjusted for age, race/ethnicity, and state of residence at time of infants birth. Gastroschisis OR were also adjusted for periconceptional smoking. RESULTS Periconceptional alcohol consumption and craniosynostosis showed little evidence of an association (OR = 0.92; CI: 0.78-1.08), but alcohol consumption in the second (OR = 0.65; CI: 0.47-0.92) and third trimesters (OR = 0.68; CI: 0.49-0.95) was inversely associated with craniosynostosis. Periconceptional alcohol consumption was associated with omphalocele (OR = 1.50; CI: 1.15-1.96) and gastroschisis (OR = 1.40; CI: 1.17-1.67). CONCLUSIONS Results suggest that maternal periconceptional alcohol consumption is associated with omphalocele and gastroschisis, and second and third trimester alcohol consumption are inversely associated with craniosynostosis.


Birth Defects Research Part A-clinical and Molecular Teratology | 2009

Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study.

Marilyn L. Browne; Sonja A. Rasmussen; Adrienne T. Hoyt; D. Kim Waller; Charlotte M. Druschel; Alissa R. Caton; Mark A. Canfield; Angela E. Lin; Suzan L. Carmichael; Paul A. Romitti

BACKGROUND Although thyroid disorders are present in approximately 3% of pregnant women, little is known about the association between maternal thyroid disease and birth defects. METHODS We assessed the association between maternal thyroid disease, thyroid medication use, and 38 types of birth defects among 14,067 cases and 5875 controls in the National Birth Defects Prevention Study, a multisite, population-based, case-control study. Infants in this study were born between October 1997 and December 2004. Information on exposures including maternal diseases and use of medications was collected by telephone interview. RESULTS We found statistically significant associations between maternal thyroid disease and left ventricular outflow tract obstruction heart defects (1.5; 95% CI, 1.0-2.3), hydrocephaly (2.9; 95% CI, 1.6-5.2), hypospadias (1.6; 95% CI, 1.0-2.5), and isolated anorectal atresia (2.4; 95% CI, 1.2-4.6). Estimates for the association between periconceptional use of thyroxine and specific types of birth defects were similar to estimates for any thyroid disease. Given that antithyroid medication use was rare, we could not adequately assess risks for their use for most case groups. CONCLUSIONS Our results are consistent with the positive associations between maternal thyroid disease or thyroid medication use and both hydrocephaly and hypospadias observed in some previous studies. New associations with left ventricular outflow tract obstruction heart defects and anorectal atresia may be chance findings.


Birth Defects Research Part A-clinical and Molecular Teratology | 2011

Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study.

Marilyn L. Browne; Adrienne T. Hoyt; Marcia L. Feldkamp; Sonja A. Rasmussen; Elizabeth G. Marshall; Charlotte M. Druschel; Paul A. Romitti

BACKGROUND Caffeine intake is common during pregnancy, yet few epidemiologic studies have examined the association between maternal caffeine consumption and birth defects. Using data from the National Birth Defects Prevention Study (NBDPS), we examined the association between maternal caffeine consumption and anotia/microtia, esophageal atresia, small intestinal atresia, craniosynostosis, diaphragmatic hernia, omphalocele, and gastroschisis. METHODS The NBDPS is a multi-site population-based case-control study. The present analysis included 3,346 case infants and 6,642 control infants born from October 1997 through December 2005. Maternal telephone interview reports of demographic characteristics and conditions and exposures before and during pregnancy were collected. Odds ratios and 95% confidence intervals, adjusted for relevant covariates, were calculated to estimate the associations between maternal dietary caffeine intake (coffee, tea, soda, and chocolate) and maternal use of caffeine-containing medications and each defect. RESULTS We observed small, statistically significant elevations in adjusted odds ratios ranging from 1.3 to 1.8 for total maternal dietary caffeine intake or specific types of caffeinated beverages and anotia/microtia, esophageal atresia, small intestinal atresia, and craniosynostosis; however, dose-response patterns were absent. Periconceptional use of caffeine-containing medications was infrequent and estimates were imprecise. CONCLUSIONS We did not find convincing evidence of an association between maternal caffeine intake and the birth defects included in this study. The increasing popularity of caffeine-containing energy drinks and other caffeinated products may result in higher caffeine intake among women of childbearing age. Future studies should consider more detailed evaluation of such products.


Public Health Reports | 2003

Watercraft-Related Drownings Among New York State Residents, 1988-1994

Marilyn L. Browne; Elizabeth L. Lewis-Michl; Alice D. Stark

Objective. To describe environmental and personal risk factors associated with watercraft-related drownings. This information may be useful in developing boating safety programs, regulations, and enforcement priorities. Methods. A companion article in this issue (Unintentional Drownings Among New York State Residents, page 448) summarizes an investigation of 883 non-bathtub drownings among New York State residents for the years 1988 to 1994 using medical examiner, coroner, police, and hospital records in addition to death certificate data. This report details the environmental and personal risk factors associated with 216 watercraft-related drownings. Results. Ninety-three percent of watercraft-related drowning victims were male, with the highest rate of drowning observed among males ages 15–44 years. Most commonly, the victim entered the water when the watercraft capsized (36%), the victim fell overboard (24%), or the victim intended to swim (11%). Personal flotation devices (PFDs) were known to be worn by only 9% of drowning victims, and in these cases other risks overwhelmed the effectiveness of the PFD. Of 73 individuals 15 years of age or older for whom adequate blood alcohol concentration analyses were provided, 44% were positive for blood alcohol. Conclusions. Based on this study, increased use of PFDs, avoidance of dangerous currents, and less alcohol use by operators and passengers of all types of watercraft would result in a reduction in watercraft-related drownings. In addition to continued education efforts, boating safety measures that deserve consideration include enforcement of current PFD and boating while intoxicated (BWI) regulations and expansion of BWI laws to apply to all boaters.

Collaboration


Dive into the Marilyn L. Browne's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charlotte M. Druschel

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

Denise M. Kay

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

James L. Mills

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michele Caggana

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

Lawrence C. Brody

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert J. Sicko

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

Alissa R. Van Zutphen

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge